[{"Assets_0_Q2_USD":4804024000.0,"EarningsPerShareBasic_1_Q2_USD":1.76,"EarningsPerShareBasic_2_Q2_USD":3.2,"EarningsPerShareDiluted_1_Q2_USD":1.72,"EarningsPerShareDiluted_2_Q2_USD":3.13,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":299631000.0,"NetIncomeLoss_1_Q2_USD":105604000.0,"NetIncomeLoss_2_Q2_USD":192115000.0,"StockholdersEquity_0_Q2_USD":2201032000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":61463000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":61321000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":60100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":59991000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]